Answers are grounded in this paper and cite their sources.
Additional haemostatic agent use is safe in PwHA undergoing surgery while receiving emicizumab. Additional data are needed to determine the optimal dosing/length of treatment of additional haemostatic agents to lower bleeding risk.
No takes yet. Share an insight, caveat, or question.
Lewandowska et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: